Logo image of COUR

COURSERA INC (COUR) Stock Fundamental Analysis

NYSE:COUR - New York Stock Exchange, Inc. - US22266M1045 - Common Stock - Currency: USD

8.51  +0.1 (+1.19%)

After market: 8.49 -0.02 (-0.24%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to COUR. COUR was compared to 73 industry peers in the Diversified Consumer Services industry. COUR has a great financial health rating, but its profitability evaluates not so good. COUR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

COUR had positive earnings in the past year.
COUR had a positive operating cash flow in the past year.
In the past 5 years COUR always reported negative net income.
In multiple years COUR reported negative operating cash flow during the last 5 years.
COUR Yearly Net Income VS EBIT VS OCF VS FCFCOUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

COUR has a Return On Assets of -6.95%. This is comparable to the rest of the industry: COUR outperforms 50.68% of its industry peers.
COUR has a Return On Equity of -10.82%. This is comparable to the rest of the industry: COUR outperforms 53.42% of its industry peers.
Industry RankSector Rank
ROA -6.95%
ROE -10.82%
ROIC N/A
ROA(3y)-13.24%
ROA(5y)-14.17%
ROE(3y)-19.16%
ROE(5y)-20.97%
ROIC(3y)N/A
ROIC(5y)N/A
COUR Yearly ROA, ROE, ROICCOUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

Looking at the Gross Margin, with a value of 53.88%, COUR is in the better half of the industry, outperforming 71.23% of the companies in the same industry.
COUR's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for COUR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.81%
GM growth 5Y0.79%
COUR Yearly Profit, Operating, Gross MarginsCOUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

COUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
COUR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, COUR has more shares outstanding
There is no outstanding debt for COUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
COUR Yearly Shares OutstandingCOUR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
COUR Yearly Total Debt VS Total AssetsCOUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

COUR has an Altman-Z score of 2.19. This is not the best score and indicates that COUR is in the grey zone with still only limited risk for bankruptcy at the moment.
COUR's Altman-Z score of 2.19 is fine compared to the rest of the industry. COUR outperforms 63.01% of its industry peers.
There is no outstanding debt for COUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.19
ROIC/WACCN/A
WACC8.96%
COUR Yearly LT Debt VS Equity VS FCFCOUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.55 indicates that COUR has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.55, COUR belongs to the top of the industry, outperforming 80.82% of the companies in the same industry.
COUR has a Quick Ratio of 2.55. This indicates that COUR is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of COUR (2.55) is better than 80.82% of its industry peers.
Industry RankSector Rank
Current Ratio 2.55
Quick Ratio 2.55
COUR Yearly Current Assets VS Current LiabilitesCOUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

5

3. Growth

3.1 Past

COUR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 230.51%, which is quite impressive.
The Revenue has been growing slightly by 7.27% in the past year.
COUR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 30.38% yearly.
EPS 1Y (TTM)230.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.43%
Revenue 1Y (TTM)7.27%
Revenue growth 3Y18.71%
Revenue growth 5Y30.38%
Sales Q2Q%6.05%

3.2 Future

Based on estimates for the next years, COUR will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.35% on average per year.
Based on estimates for the next years, COUR will show a small growth in Revenue. The Revenue will grow by 5.82% on average per year.
EPS Next Y9.71%
EPS Next 2Y16.19%
EPS Next 3Y19.35%
EPS Next 5YN/A
Revenue Next Year4.06%
Revenue Next 2Y4.48%
Revenue Next 3Y5.82%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
COUR Yearly Revenue VS EstimatesCOUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
COUR Yearly EPS VS EstimatesCOUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 21.82 indicates a rather expensive valuation of COUR.
Compared to the rest of the industry, the Price/Earnings ratio of COUR indicates a somewhat cheap valuation: COUR is cheaper than 67.12% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.22, COUR is valued a bit cheaper.
COUR is valuated rather expensively with a Price/Forward Earnings ratio of 18.54.
64.38% of the companies in the same industry are more expensive than COUR, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 20.86. COUR is around the same levels.
Industry RankSector Rank
PE 21.82
Fwd PE 18.54
COUR Price Earnings VS Forward Price EarningsCOUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, COUR is valued a bit cheaper than the industry average as 71.23% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 20.64
EV/EBITDA N/A
COUR Per share dataCOUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates COUR does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as COUR's earnings are expected to grow with 19.35% in the coming years.
PEG (NY)2.25
PEG (5Y)N/A
EPS Next 2Y16.19%
EPS Next 3Y19.35%

More info and screens

0

5. Dividend

5.1 Amount

COUR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COURSERA INC

NYSE:COUR (5/2/2025, 8:04:00 PM)

After market: 8.49 -0.02 (-0.24%)

8.51

+0.1 (+1.19%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)04-24 2025-04-24/amc
Earnings (Next)07-23 2025-07-23/amc
Inst Owners81.57%
Inst Owner Change0.18%
Ins Owners6.51%
Ins Owner Change0.84%
Market Cap1.37B
Analysts74.29
Price Target9.73 (14.34%)
Short Float %3.9%
Short Ratio3.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)71.06%
Min EPS beat(2)49.74%
Max EPS beat(2)92.38%
EPS beat(4)4
Avg EPS beat(4)292.01%
Min EPS beat(4)49.74%
Max EPS beat(4)669.94%
EPS beat(8)8
Avg EPS beat(8)1337.63%
EPS beat(12)11
Avg EPS beat(12)907.01%
EPS beat(16)14
Avg EPS beat(16)686.13%
Revenue beat(2)1
Avg Revenue beat(2)-0.13%
Min Revenue beat(2)-0.48%
Max Revenue beat(2)0.22%
Revenue beat(4)2
Avg Revenue beat(4)0.13%
Min Revenue beat(4)-0.77%
Max Revenue beat(4)1.57%
Revenue beat(8)5
Avg Revenue beat(8)0.52%
Revenue beat(12)8
Avg Revenue beat(12)0.64%
Revenue beat(16)11
Avg Revenue beat(16)1.18%
PT rev (1m)-3.38%
PT rev (3m)-7.95%
EPS NQ rev (1m)0.14%
EPS NQ rev (3m)12.36%
EPS NY rev (1m)-0.75%
EPS NY rev (3m)7.29%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)-1.41%
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)-2.38%
Valuation
Industry RankSector Rank
PE 21.82
Fwd PE 18.54
P/S 1.95
P/FCF 20.64
P/OCF 13.14
P/B 2.25
P/tB 2.34
EV/EBITDA N/A
EPS(TTM)0.39
EY4.58%
EPS(NY)0.46
Fwd EY5.39%
FCF(TTM)0.41
FCFY4.84%
OCF(TTM)0.65
OCFY7.61%
SpS4.37
BVpS3.79
TBVpS3.63
PEG (NY)2.25
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.95%
ROE -10.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.88%
FCFM 9.43%
ROA(3y)-13.24%
ROA(5y)-14.17%
ROE(3y)-19.16%
ROE(5y)-20.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.81%
GM growth 5Y0.79%
F-Score7
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 146.91%
Cap/Sales 5.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.55
Quick Ratio 2.55
Altman-Z 2.19
F-Score7
WACC8.96%
ROIC/WACCN/A
Cap/Depr(3y)108%
Cap/Depr(5y)109.75%
Cap/Sales(3y)3.84%
Cap/Sales(5y)3.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)230.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.43%
EPS Next Y9.71%
EPS Next 2Y16.19%
EPS Next 3Y19.35%
EPS Next 5YN/A
Revenue 1Y (TTM)7.27%
Revenue growth 3Y18.71%
Revenue growth 5Y30.38%
Sales Q2Q%6.05%
Revenue Next Year4.06%
Revenue Next 2Y4.48%
Revenue Next 3Y5.82%
Revenue Next 5YN/A
EBIT growth 1Y29.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year215.61%
EBIT Next 3Y73.99%
EBIT Next 5YN/A
FCF growth 1Y794.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2030.84%
OCF growth 3Y279.12%
OCF growth 5YN/A